The price of copper has tumbled as China’s leaders struggle to keep their economic plan on the road. John Stepek explains why that matters for your money.
Palladium has just had its best week in four years thanks to the bad press over diesel engines.
Electric car entrepreneur Elon Musk is plotting great things from his lair. Smart investors should get behind him, says Bengt Saelensminde.
Commodities trading and mining giant Glencore has bowed to shareholder calls to fortify the group against the slump in raw-materials prices.
Asset allocation is at least as important as individual share selection. So where should you be putting your money? Here’s September’s take on the major asset classes.
Commodities are plunging lower and that could be a signal everything else will follow. Alex Williams looks at how clever investors can still profit.
The fall in commodity prices has moved centre stage in investors’ worries, with the pace quickening in the past few days.
The Bloomberg Commodity index, which tracks 22 hard and soft raw materials, has fallen to a 13-year low.
With the arrival of ‘Formula E’, electric cars have come of age. That’s great news for lithium miners. Matthew Partridge looks at the prospects for the ‘fuel of the future’.
A new battery technology, based on lithium, is being born which could fuel big changes in mobile phones and cars. Here’s how to invest.
A new scheme coming to London is proof that electric cars are entering the mainstream, says John Stepek. Here, he looks at the next stage in the green transport revolution.
Uranium is set for a rebound after a fall in the price caused by the Fukushima disaster.
Iron ore, the main ingredient in steel, has suffered a nasty slump, with the price plummeting below $50 a ton.
The long-heralded age of the electric car might finally be upon us. Matthew Partridge looks at how to profit.
The price of palladium looks set to recover on the back soaring global car sales.
Metal prices have been battered, and with them mining stocks. But they could both be about to bounce back. Dr Matthew Partridge explains why.